CBD Life Sciences Inc (CBDL)

[GoonOfWallSt]

What a piece of junk pos turdy scam stock…

[stock king 1]

Company dirty as hell it’s selling share scam . Company doesn’t have an ounce of value except suckers buying into their lies

[packerfan9]

Duh now you get it.

[Batman412]

That would be considered fraud or stock manipulation please be quite they won't get another r/s approved revenue is up first quarter will be big army deal any minute 

[packerfan9]

They are going to sell billions. What do you think are filling buys every day? Dilution. Keep ignoring this is not the first time. Same as before last r/s. There is no share buyback. They are selling new shares.

[stock king 1]

Company crooked folks toooo many shares ceo is so full of chit

[Batman412]

You keep saying they increased the a/s when they didn't so everything else you say is irrelevant 

[packerfan9]

With what money? Buyback lol. They increased the a/s. All day every day dilution fills buys by fools.

[packerfan9]

Even with a 500% increase. Notice they never post numbers just a %. That is because revenues still tiny under 1 million. Vs the billions of dilution shares before and after r/s for the last 5 years. Volume is slowing. They will take it to .0001 again soon enough. All they care about is selling shares. 5 years of this and some still blind to it.

[stock king 1]

Ceo is about lie, steal, wash , rinse and repeat . Cbdl has no value

[stock king 1]

Ceo a flat out crook buyer beware. This ceo doesn’t give two chits about shareholders.

[Chartmaster]

CBD Life Sciences Inc. (CBDL) Company Online Sales Up 500%Press Release | 04/10/2025

With the global wellness industry exploding past $7 trillion, CBDL positions itself at the intersection of CBD, mushrooms, and modern healing - delivering real results and red-hot returns.

SCOTTSDALE, AZ / ACCESS Newswire / April 10, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is thrilled to announce a 500% increase in online sales this past quarter, catapulting the company into a new phase of growth as it rides the tidal wave of a rapidly expanding global wellness economy.

This milestone reflects the company's relentless focus on innovation, clean ingredients, and product efficacy. From cutting-edge CBD topicals to adaptogenic mushroom blends, CBDL is gaining significant traction in both consumer markets and investor circles.

"We're not just selling CBD anymore," said CEO Lisa Nelson. "We're creating a new category of functional wellness - one that blends the healing powers of CBD, mushrooms, and natural ingredients backed by science and built for today's lifestyles."

Positioned in the Heart of a $7 Trillion Wellness Boom
The wellness industry is booming - valued at $7.1 trillion globally, with natural health solutions like CBD and functional mushrooms taking center stage. CBDL is uniquely positioned at this intersection, offering products that tap into two of the most explosive markets in the world:

The CBD market, projected to exceed $60 billion by 2030

The functional mushroom market, expected to surpass $24 billion by 2032

CBD Life Sciences Inc. is going beyond traditional CBD by launching wellness-forward formulations that include Reishi, Lion's Mane, and Ashwagandha - powerful adaptogens known for reducing stress, improving focus, boosting immunity, and fighting inflammation. The company's line of CBD Kava & Kratom Shots is also gaining momentum as a natural alternative to caffeine, energy drinks, and synthetic stress relief.

CBDL's Momentum is Just Getting Started:

500%+ online sales growth in Q1 2025

Top-sellers: 3000MG Pain Relief Cream, CBD Kava & Kratom Shots, Mushroom Wellness Blends

Retail Expansion:

Now selling on Walmart Marketplace

Products available through DoorDash in select markets

More e-commerce and delivery partnerships in development

Innovative Product Development:

Proprietary Nano-CBD Technology for maximum bioavailability

Launch of adaptogenic mushroom products including Reishi, Lion's Mane, and Ashwagandha

Domestic Production & Compliance:

All products made in the USA

Third-party tested for quality and consistency

Clean-label ingredients, no artificial fillers

For Investors
CBD Life Sciences Inc. is not just scaling - it's setting the pace. By strategically expanding into multiple billion-dollar wellness verticals, CBDL is leveraging its momentum to build a brand that is future-proof, health-focused, and ready for mass market adoption.

With more consumers turning to plant-based, functional wellness solutions every day, CBDL stands at the forefront of a generational shift in how people approach health and healing.

For investors seeking to get in on the ground floor of the next wave in natural wellness, CBD Life Sciences Inc. is the name to watch.

About CBD Life Sciences Inc.
CBD Life Sciences Inc. (CBDL) is a leading innovator in the wellness and alternative health sector, specializing in high-quality CBD and functional mushroom products designed to enhance well-being. With a commitment to scientific research and consumer safety, CBDL continues to push the boundaries of holistic health solutions, creating opportunities for exponential growth in a rapidly evolving market.

Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: [e-mail]

Stay Connected & Be the First to Try Our New Functional Mushroom Products!

Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz

Mushroom Madness Website: https://www.mushroommadness.shop

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
[e-mail]
4802091720

SOURCE: CBD Life Sciences, Inc.


View the original press release on ACCESS Newswire
https://www.otcmarkets.com/stock/CBDL/news/CBD-Life-Sciences-Inc-CBDL-Company-Online-Sales-Up-500?id=473233

[konshe]

Buy back shares will be started.

[AveragePenny]

$CBDL CBD Life Sciences Inc. (CBDL) Company Online Sales Up 500%

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cbd-life-sciences-inc-cbdl-company-online-sales-up-500-1013080

With the global wellness industry exploding past $7 trillion, CBDL positions itself at the intersection of CBD, mushrooms, and modern healing - delivering real results and red-hot returns.

SCOTTSDALE, AZ / ACCESS Newswire / April 10, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is thrilled to announce a 500% increase in online sales this past quarter, catapulting the company into a new phase of growth as it rides the tidal wave of a rapidly expanding global wellness economy.

This milestone reflects the company's relentless focus on innovation, clean ingredients, and product efficacy. From cutting-edge CBD topicals to adaptogenic mushroom blends, CBDL is gaining significant traction in both consumer markets and investor circles.

"We're not just selling CBD anymore," said CEO Lisa Nelson. "We're creating a new category of functional wellness - one that blends the healing powers of CBD, mushrooms, and natural ingredients backed by science and built for today's lifestyles."

Positioned in the Heart of a $7 Trillion Wellness Boom
The wellness industry is booming - valued at $7.1 trillion globally, with natural health solutions like CBD and functional mushrooms taking center stage. CBDL is uniquely positioned at this intersection, offering products that tap into two of the most explosive markets in the world:

The CBD market, projected to exceed $60 billion by 2030

The functional mushroom market, expected to surpass $24 billion by 2032

CBD Life Sciences Inc. is going beyond traditional CBD by launching wellness-forward formulations that include Reishi, Lion's Mane, and Ashwagandha - powerful adaptogens known for reducing stress, improving focus, boosting immunity, and fighting inflammation. The company's line of CBD Kava & Kratom Shots is also gaining momentum as a natural alternative to caffeine, energy drinks, and synthetic stress relief.

CBDL's Momentum is Just Getting Started:

500%+ online sales growth in Q1 2025

Top-sellers: 3000MG Pain Relief Cream, CBD Kava & Kratom Shots, Mushroom Wellness Blends

Retail Expansion:

Now selling on Walmart Marketplace

Products available through DoorDash in select markets

More e-commerce and delivery partnerships in development

Innovative Product Development:

Proprietary Nano-CBD Technology for maximum bioavailability

Launch of adaptogenic mushroom products including Reishi, Lion's Mane, and Ashwagandha

Domestic Production & Compliance:

All products made in the USA

Third-party tested for quality and consistency

Clean-label ingredients, no artificial fillers

For Investors
CBD Life Sciences Inc. is not just scaling - it's setting the pace. By strategically expanding into multiple billion-dollar wellness verticals, CBDL is leveraging its momentum to build a brand that is future-proof, health-focused, and ready for mass market adoption.

With more consumers turning to plant-based, functional wellness solutions every day, CBDL stands at the forefront of a generational shift in how people approach health and healing.

For investors seeking to get in on the ground floor of the next wave in natural wellness, CBD Life Sciences Inc. is the name to watch.

[packerfan9]

I said before the last r/s. That even .0001 was to much to pay. Anyone who did before this r/s lost their money. To ignore the dilution scam this is. Means anyone buying will lose.

[SmellMyFinger]

$0.0001s are cheaper than $0.0003s. The reverse/split was a bad idea, as they usually are (especially for OTC stocks).

[packerfan9]

The A/S is then 6.5 billion. You will end up like all the ones before this r/s. Who all argued the same as you are. This is a dilution scam. They get rich selling shares not CBD.

[Batman412]

Nice recent buys to sells been green last few days 

[Batman412]

I'm not wrong no they didn't raise a/s so please shut the fuvk up you're not saving anybody you're just an annoying dweeb 

[packerfan9]

Wrong yes they did. How do you think buys are being filled at these levels? It is called dilution. The A/s is 6.5 billion. Maybe not 8.5. The dilution here never stops. Keep buying. You will lose it all. Ignore the dilution record here for 5 years is not very smart.

[Batman412]

Army deal and yearly coming up followed by first quarter in may well be back to 001

[Batman412]

They didn't increase the a/s your information is wrong and judging by the ease of getting the right information I believe your opinions are wrong too 

[packerfan9]

Just like before this r/s. Ticking down now ask is .0003.Some just ignore the history here but it does not change.

[packerfan9]

Under valued lol. They have diluted billions and still are. For all the dilution and r/s what did they produce? Over 5 years little as revenues are tiny. Only shares filling buys are shares sold by the company. Never ending dilution. When back and stuck at .0001 again. You will lose any money buying this stock. Just ask shareholders in before last r/s. Gone. Also they put out a lying pr saying share buyback. The increase a/s and kept on diluting. Crooks.

[konshe]

THis undervalued stock will take off soon with more good news coming.

[konshe]

Don't worry 3 is a good buy. This company has good future. Revenue will come fast, PPS is undervalued, CEO plan to buy back shares.. Now they need cash for coming merge. Dilution will stop very soon.

[packerfan9]

Everyday when they are diluting and have billions to sell. People buying this will lose it all. Same as others before the last r/s. Some people are just blind to this dilution scam. Only ones selling at these levels are the company dilution shares.

[Batman412]

Big dump eod 

[Jiddy905]

He's full of shit, OTCMARKETS CLEARLY SHOWS 6.5B.

[packerfan9]

It was news link I saw here a few weeks ago. Say you are right it is 6.5 billion. That is still billions they will dilute and lied about a share buyback. The dilution has not ended here for over 5 years. If we go back to before r/s. It is trillions on a presplit basis. Just like before the last r/s. Share holders will be diluted down to .00001 again. Not matter will it happen just when. They sell little for revenues vs all the dilition for years.

[Batman412]

Where are you seeing 8.5 billion otc markets was just updated as of 04/02/2025 at 6.5 million where are you seeing 8 

[packerfan9]

As I said and have been right for years. Dilution is again heading it to .0001. To sell billions of shares .00001 is inevitable.

[packerfan9]

Wrong a/s is now 8.5 billion. So much for the share buyback pr lie. Wake up this is and has been a dilution scam for 5 years. The sales are so tiny vs the massive dilution.

[packerfan9]

8.5 billion a/s says nothing will stop this dilution. They lied about a share buyback. They are not getting any military contract. They are a tiny company that does not sell much CBD. They lie!

[packerfan9]

The the company increased a/s to 8.5 billion. After they said they do a share buyback lie. This is doing the same as before previous r/s. When stuck again at .00001. Getting closer as they add shares to the o/s. Then will they be able to have another r/s approved is only question.

[Jiddy905]

These pop up shops are not gonna do it. We need need those armed forces contracts!!

[Batman412]

Just a few weeks ago it was trading 100+ m a day most was 400+m weekly it could but would take killer news 

[Jiddy905]

Historically has this stock ever traded 200,000,000 shares in one day?

[Batman412]

That can get traded in a day with the right news 

[Jiddy905]

They didn't increase A/S after R/S, that's bullshit! Still sitting at 6.5B.

[Jiddy905]

200,000,000 shares diluted over past month, that's 60k! That's a good one months pay.

[Jiddy905]

200,000,000 shares diluted March 2nd - April 2nd

[packerfan9]

LOL. The buys are filled by new share dilution. That is why stuck even when days of over 100 million. The dilution will never end. They have 8.5 billion A/S to sell fools. Nothing ever changes here. Massive dilution and small revenues.

[Batman412]

Nice buys 

[Batman412]

Yeah sales seem like more dilution I doubt that's all retail buy back was a lie but still they want to have some value to their stock if they're gonna sell shares everyone wants to sell at higher price even them 

[packerfan9]

The volume was big the last 3 days. No run up. Why? Massive dilution fillings buys is why. That never changes. Only share filling buys are dilution. All they care about is selling billions of shares.

[Batman412]

Few nice buys later on in the day here could be good sign where is this army news 

[packerfan9]

We will see but I agree. They likely would not get another r/s approved. They increased the A/S after lying about a share buyback. This is going the same as after prior r/s. Once down to .00001. Done as I doubt can do another r/s.

[Batman412]

They said no more r/s and I'm not sure how many more the sec would allow .. army news soon 

[packerfan9]

Wrong. They just increased a/s to 8.5 billion. This is never ending massive dilution. Just like before last r/s and now after. Before the r/s it had one spike. Just like we saw a short one after current r/s. Then like before. Big increase in A/s. Lies about share buyback then the increase. When this is stuck at .000001 like before this r/s. Buying the shares was a loser. Just ask anyone in before last r/s. The volume since that A/S increase. Insane. How do they get so many fools to buy in. SAD.